Collagen shields for corneal abrasions in the emergency department
Part of Brain & nervous system, Eyes & vision, Injuries & trauma clinical trials.
This study tests whether a collagen shield (a small protective lens) placed on the eye helps heal a corneal abrasion (a scratch on the clear surface of the eye) better than standard treatment in the emergency department. It may help reduce pain and speed healing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You have a scrape on the clear front part of the eye (cornea) in only one eye
- You are not allergic to moxifloxacin (an antibiotic eye drop) or ibuprofen
- You have not had prior eye surgery on the injured eye (except certain laser procedures)
- You do not have diabetes, shingles affecting the eye, or other conditions that reduce eye sensation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new hydrogel glue that helps heal a damaged cornea (the clear front part of the eye) without needing stitches. It may help people with certain corneal defects from injury or after surgery.
This study tests whether a collagen implant can help heal a severely damaged cornea (the clear front part of the eye) when standard treatments haven't worked. It may offer a new option to stop the cornea from breaking down further.
This trial studies collagen cross-linking, a procedure meant to strengthen a weakened cornea in people with keratoconus. It may help slow the bulging/weakening of the cornea and improve vision, and the study also uses special imaging to check changes over time.
This Phase 2 trial tests a locally delivered cell-based treatment (allogeneic mesenchymal stromal cells) to help heal long-lasting damage to the eye’s clear surface (the cornea). It may help if your cornea epithelium (surface layer) won’t improve even after standard non-surgical treatments.
This trial tests a new eye drop to see if it can safely and effectively reduce corneal scars. It is for people who have a recent corneal injury (within the last month) that resulted in a scar that affects their vision.
This trial compares two ways to manage inflammation after corneal crosslinking for keratoconus: a tiny steroid insert placed in the tear duct versus standard steroid eye drops. It aims to see which option is easier and works just as well.
Hear when a new Corneal Abrasions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.